Skip to main content

Table 2 Summary of clinical evidence examining the impact of exercise on neuropathic pain

From: Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research

Study

Diagnosis

Condition Groups

Exercise Duration

Exercise Session (frequency and duration)

Exercise Intensity

Outcome

Ziegler et al (2009)a [67]

Diabetes and myocardial infarction

NA

NA

NA

NA

Individuals who reported at least 1 h a week of leisure time sports activities year-round were at a lower risk for having neuropathic pain than those who reported less sport activity.

Kluding et al. (2012) [69]

Diabetes and metabolic syndrome

Combined (AET and RT)

10 weeks

3–4 days/week

30–50 min

AET

2–4 days/week

RT

1–2 days/week

10–20 reps

Moderate

(50–70% VO2max)

↔ Current pain

↔ Usual pain

↓ Worst pain over the past month

↑ Intraepidermal nerve fiber branching

Hamed and Raoof (2014) [70]

Diabetes and obesity

Aerobic

15 weeks

Moderate

3 days/week

50 min

HIIT

3 days/week

20 min

Moderate

(50–60% MHR)

Vigorous

(85–95% MHR)

↓ Pain for HIIT compared to moderate intensity

Yoo et al. (2015) [71]

Diabetes

Aerobic

16 weeks

3 days/week

30–50 min/day

Moderate

(50–70% VO2 reserve)

↔ Pain intensity

↓ Pain interference

Chiang et al (2016)a [68]

Diabetes

NA

NA

NA

NA

Participants who reported 30 min or more per day of exercise had lower odds of having neuropathic pain compared to those who reported less than 30 min per day of exercise and those who reported no exercise.

Nadi et al. (2017) [72]

Diabetes

Vitamin D only

Vitamin D + combined (AET and RT)

12 weeks

3 days/week

60 min/day

Moderate

(AET

50-70% MHR

RT

50% 10-RM)

↓ Pain

Stubbs Jr. et al. (2019) [73]

Diabetes

Health education

Aerobic

Resistance

Combined (AET and RT)

12 weeks

Health Education:

12 sessions

Exercise:

3 days/week

30–45 min/day

Moderate

(60–90% VO2peak)

↔ Vibration detection threshold (all programs)

↔ Cooling detection threshold (all programs)

↔ Heat pain threshold (all programs)

Cox et al. (2020) [74]

Diabetes

Usual care

Combined

(AET and RT)

Combined HIIT

(AET and RT)

8 weeks

Combined:

4 days/week

52.5 min/day

Combined HIIT:

3 days/week

26 min/day

Moderate

(55–69% HRpeak; fairly light to somewhat hard)

Vigorous

(85–95% HRpeak; very hard)

↓ Musculoskeletal pain (combined HIIT only)

↔ Neuropathy symptoms (all conditions)

↔ Cooling detection threshold (all conditions)

↔ Warm detection threshold (all conditions)

↔ Vibration detection threshold (all conditions)

↔ Mechanical detection threshold (all conditions)

↔ Vibration detection threshold (all conditions)

↔ Pressure pain threshold (all conditions)

Wonders et al. (2013) [75]

CIPN

Home-based

combined (AET and RT)

10 weeks

AET:

2–5 days/week

10–30 min/day

RT:

3 days/ week

Moderate

(55–65% MHR)

↓ Pain

Dhawan et al. (2019) [76]

CIPN

Usual care

Home-based (RT and balance)

10 weeks

RT & Balance

7 days/week

30 min/day

Not indicated

↓ Pain (RT and balance)

Mols et al. (2015)a [66]

Colorectal cancer survivors

NA

NA

NA

NA

There were fewer people who reported aching/burning pain, trouble handling small objects, pain, trouble standing/walking, weakness, cramps, and loss of strength in their hands in individuals who had chemotherapy and met the national PA guidelines compared to individuals who had chemotherapy and did not meet the national PA guidelines.

Maharaj et al. (2018) [77]

HIV distal symmetrical polyneuropathy

Control:

HIV education

Aerobic

Resistance

12 weeks

3 days/week

30 min/day

Low–moderate

(AET

40–65% MHR

RT

40–65% 1-RM)

↓ Pain intensity (AET; RT)

  1. aindicates an observational study
  2. Studies are grouped by diagnosis then organized chronologically. AET Aerobic training, CIPN Chemotherapy-induced peripheral neuropathy, HIV Human immunodeficiency virus, HRpeak Peak heart rate, MHR Maximal heart rate, NA Not applicable, rep Repetition, RT Resistance training, RM Repetition maximum test, ↓ = decrease in outcome, ↑ = increase in outcome, ↔ = no change in outcome